Abstract
In the heart, Ca2+ influx via CaV1.2 L-type calcium channels (LTCCs) is a multi-functional signal that triggers muscle contraction, controls action potential duration, and regulates gene expression. The use of LTCC Ca2+ as a multi-dimensional signalling molecule in the heart is complicated by several aspects of cardiac physiology. Cytosolic Ca2+ continuously cycles between ∼100 nM and ∼1 μM with each heartbeat due to Ca2+ linked signalling from LTCCs to ryanodine receptors. This rapid cycling raises the question as to how cardiac myocytes distinguish the Ca2+ fluxes originating through L-type channels that are dedicated to contraction from Ca2+ fluxes originating from other L-type channels that are used for non-contraction-related signalling. In general, disparate Ca2+ sources in cardiac myocytes such as current through differently localized LTCCs as well as from IP3 receptors can signal selectively to Ca2+-dependent effectors in local microdomains that can be impervious to the cytoplasmic Ca2+ transients that drive contraction. A particular challenge for diversified signalling via cardiac LTCCs is that they are voltage-gated and, therefore, open and presumably flood their microdomains with Ca2+ with each action potential. Thus spatial localization of Cav1.2 channels to different types of microdomains of the ventricular cardiomyocyte membrane as well as the existence of particular macromolecular complexes in each Cav1.2 microdomain are important to effect different types of Cav1.2 signalling. In this review we examine aspects of Cav1.2 structure, targeting and signalling in two specialized membrane microdomains—transverse tubules and caveolae.
Keywords: L-type calcium channel, T-tubule, Caveolae, Channel trafficking, Calcium signalling
1. Cardiac L-type channel-structure function
High-voltage-activated calcium (CaV) channels convert electrical signals into Ca2+ influx to trigger biological responses in excitable cells. CaV channels are multi-subunit protein complexes comprised of a pore-forming α1 subunit assembled with auxiliary (β, α2δ, and γ) subunits, and calmodulin (Figure 1). There are seven different types of CaV channel α1 subunit (CaV1.1–CaV1.4 and CaV2.1−CaV2.3) encoded by different genes.1 Under normal conditions, adult ventricular myocytes express only the CaV1.2 α1C subunit.
Figure 1.

Schematic of the cardiac CaV1.2 LTCC complex. The channel complex consists of a pore-forming α1C subunit assembled with accessory proteins (β, α2δ, γ, and calmodulin). The α1C subunit contains four homologous domains (I–IV), each with six transmembrane segments (S1–S6). The S1–S4 segments comprise the voltage sensor, and the S5–S6 segments from each domain collaborate to form the channel pore and selectivity filter.
1.1. The pore-forming α1C subunit
The LTCC α1C subunit contains four homologous domains (DI−DIV) each with six membrane-spanning segments (S1–S6) connected by intracellular loops and bracketed by cytosolic N- and C-termini. The S1–S4 segments from each domain comprise the voltage sensor, whereas the four S5–S6 segments form the channel pore and contain the selectivity filter.1 The α1C subunit undergoes extensive alternative splicing, and transcript scanning of human heart cDNA libraries indicates the existence of multiple α1C splice variants.2 The functional significance of α1C alternative splicing in the heart is unknown, although experiments in heterologous cells indicate some alternatively spliced CaV1.2 variants display moderate changes in channel gating and/or trafficking.2,3 Although the α1C mRNA predicts a protein of 240 kDa protein, western blots of heart tissue typically show an additional prominent band at 190 kDa. This is attributed to post-translational cleavage of α1C in the C-terminus creating two fragments of 190 and 50 kDa, respectively.4 In heterologous cells, the cleaved α1C C-terminus non-covalently associates with the main body of the channel and inhibits channel activity.5 The α1C C-terminus is important for channel trafficking to the cell surface,6 and is a critical site of interaction for signalling proteins that either modulate LTCCs or decode local Ca2+ signals.7 Knock-in mice expressing α1C with a deleted distal C-terminus display dramatically reduced LTCC surface density and currents.8
1.2. CaVβ subunit
There are four distinct CaVβ subunits (β1–β4) each with multiple splice variants.9,10 All CaVβs contain a conserved core comprised of src homology 3 (SH3) and guanylate-kinase like (GK) domains and three variable unstructured regions—N-terminus, C-terminus, and a HOOK domain that separates SH3 and GK.11–13 An α1-binding pocket (ABP) in the CaVβ GK domain binds with high (nM) affinity to a conserved 18-residue α1 interaction domain (AID) located in the domain I–II intracellular loop of pore-forming α1 subunits.14 In heterologous cells, CaVβs dramatically increase the trafficking of CaVα1 subunits to the plasma membrane.9,10 For CaV1.2, the mechanism involves β-subunit binding to α1C I–II loop and causing rearrangement of α1C intracellular loops in a manner that shifts a balance of power between export signals on the I–II loop and retention signals elsewhere.6 In addition, CaVβs prevent targeting of CaVα1 subunits to the proteasome leading to increased surface expression.15,16 Beyond enhancing trafficking, CaVβs also regulate multiple channel-gating properties including: increasing channel open probability (Po), causing a hyperpolarizing shift in the voltage-dependence of activation, and imparting unique profiles of voltage-dependent inactivation.9,10
There appears to be species differences in the complement of β subunit isoforms expressed in adult mammalian heart. In adult mouse heart, only β2 is detected at the protein level.17 β2 has five splice variants (β2a–β2e) that differ only in their N-termini.18 In heterologous cells, these impart unique inactivation and single-channel-gating signatures.18,19 In contrast to mouse, all four β-subunit proteins are detected in the canine myocardium, where immunofluorescence and fractionation experiments suggest that they have distinct sub-cellular distributions.20 The functional significance of having diverse CaVβ isoforms and splice variants in the heart is unknown. Knockout of β2 in mice is embryonic lethal due to impaired cardiac development that is secondary to a decreased L-type Ca2+ current (ICa,L).21 Surprisingly, cardiac-specific excision of β2 in adult mice substantially knocked-down β2 protein (by 96%), but only moderately decreased ICa,L (by 29%),17 suggesting that CaVβ may not be critical for α1C trafficking in adult ventricular myocytes. A contrasting viewpoint is provided by a study in which shRNA-mediated knockdown of β2 in adult rat myocytes substantially diminished ICa,L.22 Moreover, over-expressing CaVβs in isolated adult heart cells and in transgenic mice markedly increases ICa,L and tunes channel voltage-dependent inactivation and single-channel-gating properties according to the β isoform expressed.23,24
1.3. α2δ subunit
There are four α2δ subunit isoforms (α2δ-1–α2δ-4). These proteins are the product of a single gene that is post-translationally cleaved into separate α2 and δ peptides held together by disulphide bonds.25,26 The large α2 protein is entirely extracellular and tethered to the plasma membrane via the δ subunit which has a short hydrophobic region that traverses the membrane in the manner of a type 1 transmembrane protein. It has also been shown that some α2δ subunits can anchor to the plasma membrane using a glycosylphosphatidylinositol (GPI) anchor.26 The α2 proteins contain a von Willebrand A (VWA) domain, a protein–protein interaction motif found in many proteins including integrin receptors and extracellular matrix proteins involved in cell adhesion.27 The α2δ VWA domains contain a metal ion-dependent adhesion site (MIDAS).25–27 The α2 proteins also contain a Cache domain, a signalling motif held in common with some prokaryotic chemotaxis receptors.25,28 In general, α2δ subunits increase the amplitude of LTCC currents by approximately two- to three-fold in heterologous systems, and modulate current kinetics and voltage-dependence.29,30 The mRNA for α2δ-1 and α2δ-2 has been detected in heart, α2δ-3 is exclusively expressed in rat atria, and α2δ-4 is not present in the heart. α2δ-1 knockout mice display a significantly reduced ICa,L (45% decrease), slowed inactivation, and depolarizing shifts in the voltage-dependence of activation and inactivation.31 In neurons, α2δ subunits interact with the extracellular matrix protein thrombospondin and promote synaptogenesis.32 It is unknown whether α2δ subunits have similar functionally relevant interactions with extracellular matrix proteins in the heart.
1.4. γ subunit
There are eight distinct γ isoforms (γ1–γ8).33 Topologically, γ subunits are membrane proteins with a predicted four membrane-spanning segments and intracellular N- and C-termini. The cDNA of four γ subunit isoforms (γ4, γ6, γ7, and γ8) has been detected in human heart, although only γ6 expression has been confirmed at the protein level in rat heart.34 In heterologous expression studies all these four γ subunits co-immunoprecipitate with CaV1.2 α1C subunit.34 Functionally, they produce distinctive effects on CaV1.2 current amplitude and voltage-dependence of gating in a manner that is dependent on the β-subunit isoform present within the channel complex.34 Nevertheless, the functional impact of γ subunit expression and diversity on CaV1.2 channel targeting and signalling in heart cells is unknown.
1.5. Calmodulin
LTCCs undergo negative and positive feedback modulation by Ca2+ ions termed Ca2+-dependent inactivation (CDI) and Ca2+-dependent facilitation (CDF), respectively.35 The ubiquitous Ca2+-sensing protein, calmodulin (CaM), is the Ca2+ sensor for both CaV1.2 CDI and CDF.36,37 At resting intracellular Ca2+, CaM is associated with CaV1.2 channels.38 The proximal CaV1.2 α1C C-terminus contains critical structural elements (EF hand, pre-IQ, and IQ regions) necessary for apoCaM and Ca2+-CaM binding and transduction of CDI and CDF.35 Crystal structures of Ca2+-CaM bound to either the α1C IQ peptide,39,40 or pre-IQ–IQ region have been described.41,42 Beyond, endowing Ca2+-dependent regulation, CaM binding to the α1C C-terminus is also important for targeting CaV1.2 to the cell surface.43 The physiological importance of CaM regulation of LTCC in the heart has been demonstrated in two ways. First, over-expressing a mutated CaM (CaM1234) that no longer binds Ca2+ in adult cardiac myocytes eliminates LTCC CDI and results in ultra-long action potentials.44 Secondly, mice expressing a mutation (IQ to EQ) that disrupts CaM binding to α1C displayed a lower LTCC current, developed cardiomyopathy, and died prematurely.45
2. L-type channel targeting in T-tubules
2.1. Channel lifespan as an estimate of dynamic trafficking
Cardiac ion channels occur at specific membrane sub-domains and in specific densities. Both localization and density remain remarkably consistent over the cardiac lifespan. Given that there is little or extremely slow (well less than 10% per year) turnover of cardiomyocytes,46 a natural conclusion would be that the ion channels within each cardiomyocyte are equally stable. However, studies that measure channel turnover reveal otherwise. Connexin43, the most well-studied cardiac channel protein, has a half-life of 1–3 h.47 In non cardiac systems, potassium channels have a turnover rate of about 2 h.48 L-type calcium channel half-life is not as well explored in the heart, but in cell lines and neurons Cav1.2 protein has a half-life of about 3 h.49 Our personal recordings of Cx43 and L-type calcium channel membrane turnover in cardiomyocytes, which were used to design pharmacological interventions that affect their trafficking50–53 concur with the multiple hour timeframes reported in the literature. It is remarkable to consider that over the course of any day, most channels in our hearts are newly formed and ‘older’ channels degraded. Channel half-lives on the order of hours also indicate that trafficking to and from the membrane is highly dynamic and must be well regulated.
In the last two decades it has been increasingly clear that channel trafficking to the plasma membrane relies on cytoskeleton-based transport. Cytoskeletal components are easily able to accommodate rapid transport. For instance, kinesin-1-based transport along microtubules occurs at a rate of about 1 µm per second,54,55 which is theoretically fast enough to cover the 100 µm longitudinal axis of a ventricular cardiomyocyte in <2 min. Cytoskeletal components themselves are not static. Individual microtubule fibres are dynamic and can grow as well as suffer catastrophe all within several minutes.56 Thus the cytoskeleton delivery apparatus can well accommodate both ongoing steady-state trafficking and a sudden change in trafficking needs such as during adrenergic-mediated cardiac high output states or during acute cardiac injury.
We recently found that for Connexin43-based gap junction channels, more than 80% of the cytoplasmic channels are stationary and associated with actin fibres.53 Given the high turnover rate of channel protein, it is possible that there is a ready-made and constantly refreshed reservoir of channel that occurs below the plasma membrane and can be delivered to the membrane on a very short notice. Given the rapid turnover of all cardiac ion channels, intracellular reservoirs could contain ready-made redundant channel whose purpose is to maintain or increase density of channel in the plasma membrane. These reservoirs could buffer channel density in conditions of stress or insult.
The possibility exists (and is not well tested) that while overall channel protein turnover rate is high, functional channels that have been inserted in the plasma membrane may be less stable or, if anchored by scaffolding proteins, may be more stable than their cytoplasmic counterparts. For instance, pulse-chase experiments identified that membrane-bound Cav1.2 has a half-life as short as 3 h,49 whereas total cellular Cav1.2 half-life could be as much as 25 h.57 Thus the plasma membrane population of channel can turn over more quickly that total channel protein turnover. Accurate measurement of channel life cycles involves a combination of pulse-chase experiments with biochemical separation between plasma membrane-bound and general cytoplasmic populations, combined with detailed live cell imaging with tags that can be used to mark channels at certain times such as photoconversion of fluorescent colours. We encourage such studies in the future to understand the timing of channel localization in each phase of its life-cycle. Such studies would require primary cardiomyocytes and, for L-type calcium channel studies, further segregation would be necessary between the T-tubule membrane component and non-T-tubule plasma membrane.
2.2. Forward transport to T-tubules
Post-transcription and translation, the proteins that form cardiac ion channels such as Cav1.2 for the L-type calcium current are completed in the Golgi apparatus where they are also inserted in membrane vesicles for delivery to the plasma membrane (Figure 2). The cytoskeleton transports the vesicles to the plasma membrane, with most studies focusing on microtubules as the fibres responsible for forward transport.58–63 A critical aspect of forward transport in cardiomyocytes is localization to membrane sub-domains. It is entirely possible that channels may be delivered to random regions of the plasma membrane, only to later laterally diffuse to their appropriate sub-domain.59 However, the temporal and stochastic inefficiency of non-specific channel insertion, together with unexplained mechanisms of subsequent lateral localization other than chance interaction with a sub-domain-specific anchor protein, suggests that specificity of delivery from the Golgi to the surface sub-membrane may also occur. We previously found the Cx43 gap junctions are localized to cell–cell-bordered regions by a combination of the plus-end-tracking proteins EB1 and p150 (Glued) at the microtubule ends, and the adherens junction membrane complex, which captures the EB1-tipped microtubules, to allow for Cx43 hemichannels to be offloaded onto adherens junction-containing membrane.51,53,60,64 This directed targeting paradigm of ion channel delivery also holds for LTCCs,50 as we discuss below.
Figure 2.
Forward trafficking of cardiac ion channels. Post-transcription and translation, cardiac ion channels are packaged into vesicles and transported by the microtubule cytoskeleton to specific sub-domains on the plasma membrane. Specificity of final delivery of connexon 43 channels to gap junctions is due, in part, to the connexon protein, the microtubule plus-end-tracking proteins EB1 and p150(Glued) and the adherens junction complex serving as membrane anchor. Specificity of final delivery of Cav1.2 channels to T-tubules is due, in part, to Cav1.2 protein, and BIN1 serving as membrane anchor. Microtubule plus-end-tracking proteins have not yet been determined for Cav1.2 to T-tubule trafficking. It has also been identified that the actin cytoskeleton slows down forward delivery and is associated with the majority of cytoplasmic Connexin 43 containing vesicles, possibly serving as sorting and reservoirs related rest stops on the way to the plasma membrane. Presumably actin fibres function in a similar capacity for Cav1.2 delivery.
T-tubule invaginations of ventricular cardiomyocyte plasma membrane occur with a species-dependent spatial period of several micrometres and are enriched with L-type calcium channels. This local enrichment is necessary for calcium-induced calcium release with nearby ryanodine receptors, which is important for beat-to-beat excitation–contraction (EC) coupling in the heart. An understanding of LTCC trafficking to T-tubules is beginning to emerge. As discussed earlier in this review, the β subunit is generally necessary for surface expression.6 Moreover, the α2δ subunit synergizes with the β subunit to promote surface channel expression.65 These auxiliary subunits enhance surface expression by promoting channel export from the ER and can also stabilize the channel on its journey to the membrane, and limit internalization.66 It is possible that subunits contribute to localization to particular plasma membrane-specific sub-regions such as T-tubules, but data for such a phenomenon are presently lacking.
Several years ago we found that Cav1.2-based channels adhere to the directed targeting paradigm.50 In particular, the membrane scaffolding protein BIN1 which lines T-tubules provides the membrane anchor that attaches dynamic microtubules, allowing delivery of LTCCs directly to T-tubule membrane. Using HL-1 cells that express Cav1.2 but not T-tubules, and non-muscle cell lines that do not either express Cav1.2 or naturally form T-tubules, we found that exogenous BIN1 caused the formation of deep invaginations in the cell membrane enriched with endogenous or overexpressed Cav1.2, suggesting that BIN1-containing membrane without other typical cardiac muscle proteins is sufficient to recruit LTCCs. To test the possibility that BIN1 serves as an anchoring site for microtubules on which Cav1.2 channels are trafficked, we tracked growing microtubules extending towards BIN1 clusters and found that the microtubule free ends pause and associate with BIN1 clusters at the cell periphery. Moreover, we determined that the non-BAR domains are required for this activity as truncation mutants lacking these domains failed to cluster Cav1.2 at cell surface invaginations. The microtubule plus-end-tracking protein that may aid in microtubule anchoring to BIN1 has not yet been identified.
Unresolved issues in the directed targeting paradigm is where in the pathway to the membrane is specificity of delivery obtained and whether the minimal subset of channel, microtubule plus-end-tracking protein, and membrane anchor are sufficient to get each channel to its respective sub-domain. There is considerable evidence that specificity of delivery is obtained early in the Golgi apparatus, in effect membrane-bound vesicles receive their ‘postal address’ early in the transport pathway.67 Alternatively, vesicles may obtain specificity en route to the plasma membrane. Actin-based rest stops on the trafficking highway53 may be opportunities for either different microtubules or additional accessory-guiding proteins to be utilized to bring each channel to its appropriate sub-domain. Biochemical-based inquiries will aid exploration of trafficking-related binding partners of Cav1.2 such as calmodulin, GPCRs, and AKAP79 as well as other proteins that make up the LTCC.66 Furthermore, detailed live cell imaging can allow the pathway of the LTCC to be investigated as it exits the Golgi and makes its way to T-tubule membrane.
2.3. T-tubule membrane as destination
An intriguing and certainly controversial possibility about T-tubule membrane is that it undergoes dynamic remodelling. In mice and rats, T-tubule networks are deeper and more extensive than in rabbit and humans.52,68,69 In general, the extent of a T-tubule network in ventricular myocytes is proportional to the host heart rate70 due to the need for faster and uniform EC coupling at higher rates. However, heart and myocyte size, as well as chamber and myocyte cell type, all impact the expected extent of each T-tubule network. It remains an active area of interest to explore both the genetic determinates of T-tubule development and changes in a T-tubule network due to environmental and metabolic factors. Furthermore, it is known that the heart is able to contract without T-tubules. In mice and rats, T-tubules develop only in the second to fourth weeks of life.71 Therefore, embryonic and neonatal hearts in these animals have organized sarcomeres and generate a blood pressure, but without T-tubules. Similarly, T-tubule networks have not been reported for avian, reptile, and amphibian hearts.72,73
Not only do embryonic and neonatal hearts not need T-tubules, but T-tubules are also lost over time in disease and culture conditions. Isolated cardiomyocytes are viable yet rapidly loose their T-tubules over the first 3 days of culture.74 Interestingly, actin stabilization limits cell culture-associated T-tubule loss.74,75 It has also been reported in animals and humans that both ischaemic and non-ischaemic heart failure (HF) is associated with T-tubule remodelling with less-deep and less-dense T-tubule networks in ventricular cardiomyocytes.76–80 The mechanisms of T-tubule loss in HF are not well understood.
The lack of T-tubules in embryonic and neonatal hearts, and the reduction of T-tubules in culture and disease indicate that T-tubules are very important but not fixed and vital structures of the cardiomyocyte and that without appropriate signalling and environmental conditions, T-tubules will recede. T-tubules may be present to optimize cardiac function, but are not essential to cardiomyocyte survival. Thus T-tubules can be dynamic structures that are continuously generated and degraded. Stress may inhibit de novo tubule membrane formation while maintaining or accelerating degradation. In a recent report52 we found that calcium channels are intracellular localized in human HF, and that transcription of their membrane anchor, BIN1, is reduced. The most straightforward conclusion from this finding is that, without its membrane anchor, calcium channels are no longer delivered to T-tubules. However, BIN1 is also part of the membrane sculpting BAR domain family. It is an untested possibility that BIN1 reduction not only reduces trafficking of LTCCs to T-tubules, but decreased BIN1 is a contributing factor to disease-related reduction of T-tubule membrane. Many cell types release small (100–1000 nm) vesicles of plasma membrane known as microparticles.81 BIN1-containing microparticles are present in blood82 and plasma-derived BIN1 levels are reduced in HF, correlating with the clinical assessment of cardiac status and predicting ventricular arrhythmia.82 These findings suggest that remodelled T-tubule membrane is not just internalized, but also externalized and released into blood.
The existence T-tubule membrane turnover adds additional complexity to understanding LTCC trafficking of T-tubules. In a homeostatic equilibrium, not only would LTCC forward trafficking be needed to compensate for the rate of LTCC internalization, but also for the rate of T-tubule membrane loss. We hasten to add that despite the provocative data that suggest continuous T-tubule remodelling, such a phenomenon remains to be proven.
2.4. LTCC internalization from T-tubules
General internalization of LTCCs is poorly understood with a severe paucity of studies conducted in cardiomyocytes. Evidence exists that the beta subunit can enhance dynamin-dependent internalization in oocytes,83 and that neurons may undergo depolarization and calcium-dependent internalization.84 The reader is referred to several excellent reviews on LTCC internalization in neurons and other cells lines.66,85 We could not identify published primary data on LTCC internalization from cardiomyocyte T-tubules.
3. L-type channel targeting and signalling in caveolae
3.1. Caveolae
Caveolae are a type of lipid raft and appear as small 50- to 100-nm diameter flask-shaped invaginations of the plasma membrane that are enriched in cholesterol and sphingolipids.86 They are defined by the presence of 18–22 kDa caveolin proteins, of which there are three types (caveolin 1–3). Muscle cells predominantly contain caveolin-3. Caveolins are hairpin-shaped proteins characterized by: a central membrane-associated region; cytoplasmic N- and C-termini; an oligomerization domain that permits their self-association; and a scaffolding domain that binds signalling proteins.86 In addition to caveolins, another class of cytosolic proteins, the cavins, is necessary for caveolae formation.87 Many signalling proteins are found to be concentrated in caveolae in different cell types, leading to the notion that these structures act as important organizational centres for cellular signalling. Typically, proteins target to caveolae using a hydrophobic caveolin-binding motif (ΦXXXXΦXXΦ and ΦXΦXXXXΦ, where Φ is an aromatic residue) that binds the caveolin scaffold domain.86
3.2. CaV1.2 targeting to caveolae
Electron microscopic studies of cardiac myocytes identify a high density of caveolae in the surface sarcolemma, and at a lower density in T-tubules where they are excluded from dyadic junctions.88 Several lines of evidence indicate that a subset of LTCCs in ventricular myocytes reside in caveolae. First, immunogold-labelled CaV1.2 has directly been observed in caveolae by electron microscopy.89 Secondly, cell fractionation and western blotting experiments indicate that a portion of cardiac CaV1.2 is present in detergent-resistant membranes that contain caveolin-3.89 Thirdly, immunoprecipitation of CaV1.2 in heart cells pulls down caveolin-3 and vice versa.89,90 Fourthly, quantitative co-immunofluorescence experiments demonstrate a subset of CaV1.2 co-localized with caveolin-3.91,92 A caveat for these last two is that a subset of caveolin-3 on the cardiac myocyte surface, such as those present in T-tubules, is probably not associated with caveolae. Estimates of the fraction of CaV1.2 present in caveolae range from ∼25% of CaV1.2 in adult feline ventricular myocytes93 to ∼50% in mice.90 The molecular determinants and mechanisms responsible for CaV1.2 trafficking to caveolae in the heart are unknown, but presumably involve direct interactions between caveolin-3 and specific subunit/s within the LTCC complex. Studies aimed at identifying the specific molecular interactions responsible for CaV1.2 targeting to caveolae in the heart are required to determine whether caveolae-targeted CaV1.2 channels are molecularly distinct from those targeted to T-tubules.
3.3. Signalling function of caveolae CaV1.2 channels
There are conflicting data as to whether caveolae-localized CaV1.2 channels participate in EC coupling in adult ventricular myocytes. Geometrically, 50-nm diameter caveolae cannot be accommodated at dyadic junctions where CaV1.2 channels and ryanodine receptors approach within 12–20 nm of each other, a physical constraint confirmed by electron microscopy.88 Hence, it might be expected that caveolae LTCCs would not contribute appreciably to the Ca2+-induced Ca2+ release that underlies ventricular EC coupling. However, acutely eliminating caveolae in adult rat ventricular myocytes with methyl-β-cyclodextrin resulted in diminished Ca2+ transient amplitude and cell shortening accomplished by a decrease in the gain of EC coupling.94 Immunofluorescence experiments indicate that caveolin-3 co-localizes with a fraction of extradyadic RYRs.91 One possibility is that CaV1.2 localized in such non-dyadic RYR-neighbouring caveolae contributes to or modulates EC coupling in adult ventricular myocytes.94
An alternative view is that caveolae-localized CaV1.2 channels do not participate in EC coupling but instead act locally to control other Ca2+-dependent signalling processes in the heart cells.93,95 For example, it has been hypothesized that caveolae-localized CaV1.2 channels selectively signal to the nucleus via the transcription factor NFAT (nuclear factor of activated T cells).93 To test this idea, Houser et al.93 recently developed an approach to selectively inhibit caveolae-localized LTCCs that takes advantage of RGK (Rad, Rem, Rem2, and Gem/Kir) proteins, a family of Ras-like GTPases that potently inhibit CaV channels.96,97 Rem autonomously targets to the plasma membrane using a polybasic C-terminus extension, and this localization is important for CaV channel inhibition.98,99 The Houser group replaced the Rem C-terminus with a caveolin-targeting motif, creating Rem265-cav. When expressed in adult feline ventricular myocytes, Rem265-cav is targeted to caveolae and prevents activity-dependent GFP-NFAT translocation to the nucleus without compromising contractility or Ca2+ transient amplitude.93
It is not straightforward to envision how caveolae LTCCs can be used to activate NFAT signalling in the heart in a manner that is tightly regulated and specific. This is because LTCCs, being voltage-gated ion channels, open with each cardiac action potential and flood their microdomain with a high local [Ca2+] estimated to be in the ∼100 μM range. Therefore, there must be mechanisms in place to ensure that caveolae LTCCs do not non-specifically activate NFAT signalling during normal physiological cardiac action potentials. One hypothetical possibility is that caveolae-localized CaV1.2 channels are held in an inactive low open probability state until acted upon by a second signal (such as phosphorylation initiated by a hypertrophic hormone). Such a mechanism would be analogous to the inactivation of endothelial nitric-oxide synthase (eNOS) when it is targeted to caveolae.100 However, there is no evidence for this type of regulation of CaV1.2 in the heart since acute ablation of caveolae in adult rat ventricular myocytes had no impact on LTCC current amplitude.94 Nevertheless, direct measurements of local caveolae Ca2+ signals is necessary to either convincingly rule in or rule out the possibility that caveolae LTCCs in the heart are normally held in an inactive state. Alternatively, specificity in the LTCC to NFAT signalling pathway may be conferred by the Ca2+-decoding properties of Ca2+-sensitive effector proteins present in the caveolae LTCC microdomain.
3.4. Ca2+-sensing effectors: CaM, calcineurin, and CaM kinase II
There are two functionally distinct pools of CaM in the LTCC microdomain whose properties have been recently reviewed.101 First, there is CaM that is associated with the CaV1.2 C-terminus as a virtual subunit and is the sensor for CDI. Secondly, there is a local pool of signalling CaM that when calcified can be used to locally activate Ca2+-CaM-dependent effector proteins such as calcineurin and Ca2+-CaM-dependent protein kinase II (CaMKII). The total CaM concentration ([CaM]) in myocytes is ∼6 μM, of which only 50–75 nM is free CaM. Mori et al. used CaV1.2 fused to single CaM molecules as a biosensor to estimate a local [CaM] of 2.5 mM in the LTCC microdomain in HEK 293 cells, several orders of magnitude above the measured total cellular free [CaM] of 50 nM.102 The precise mechanism underlying such local CaM enrichment is unknown, but could involve apoCaM bound to CaM buffer proteins. Whether CaM is similarly enriched in the microdomain of LTCCs in cardiomyocytes has yet to be directly confirmed. CaM consists of two lobes (N- and C-lobes) joined together by a central α helix, with each lobe containing two Ca2+-binding EF hand motifs.35 The two lobes differ in their affinity for Ca2+ (N-lobe Kd ∼12 μM; C-lobe Kd ∼1 μM) and the kinetics of Ca2+ dissociation (∼1000 s−1 for N-lobe; ∼10 s−1 for C-lobe).101 Furthermore, the affinity and kinetics of Ca2+ binding can dramatically be altered by CaM binding to target proteins.101 The relatively low affinity of CaM for Ca2+ makes it selectively responsive to microdomains of high [Ca2+] occurring at the mouth of LTCCs and other Ca2+ sources in myocytes (e.g. RyRs and IP3Rs) rather than the bulk cytosolic 1 μM-amplitude Ca2+ transients that drive contraction. The fast dissociation kinetics of Ca2+ from the N-lobe ensures that once calcified, CaM travels a distance of ∼100 nm before losing Ca2+ bound to the N-lobe, effectively restricting the range of action of calcified CaM to the microdomain of the activating Ca2+ source.
Calcineurin, a serine-threonine phosphatase, is a heterodimer comprised of catalytic (CnA) and regulatory (CnB) subunits. CnA (∼60 kDa) consists of an N-terminal catalytic domain, a helical CnB-binding region, a CaM-binding region, and a C-terminus autoinhibitory peptide that binds the catalytic domain to keep the enzyme in an inactive state.103 CnB (∼19 kDa) contains four EF hands, and under basal (low Ca2+) conditions binds to CnA in a manner that renders the CaM-binding region unavailable for CaM association. Ca2+-dependent activation of calcineurin takes place in several steps.103 First, Ca2+ binds to CnB causing a conformational change that makes the CaM-binding region available. In this state, the enzyme is partially active (10% of full activity). Secondly, Ca2+-CaM binds the exposed CaM-binding region of CnA, causing a conformational change that relieves the action of the autoinhibitory peptide on the catalytic domain, resulting in full enzymatic activity.
The link between calcineurin and NFAT activation was first described in activated T lymphocytes, but is now recognized as a widespread signalling paradigm in many systems, including in the heart. Under basal conditions, NFAT is phosphorylated and trapped in the cytosol. Activated calcineurin dephosphorylates NFAT, allowing its translocation into the nucleus where it initiates transcription of NFAT-responsive genes. Chronic activation of the calcineurin/NFAT signalling pathway causes pathological cardiac hypertrophy in the heart.104,105 Three distinct sarcolemmal sources of Ca2+ have been linked to activation of calcineurin in the heart—LTCCs, T-type Ca2+ channels, and TRPC channels.24,106–108 Experiments in neonatal rat ventricular myocytes suggest that LTCCs may be most tightly coupled to calcineurin–NFAT signalling.108
In the heart, calcineurin is part of a macromolecular complex with CaV1.2 channels90,109 (Figure 3). Two distinct binding sites have been identified for calcineurin targeting to the CaV1.2 macromolecular complex. First, calcineurin binds to the A kinase-anchoring protein, AKAP 5 (also known as AKAP 79 and AKAP 150).90 Secondly, calcineurin binds directly to the CaV1.2 N- and C-terminus.109 The role of calcineurin binding to the CaV1.2 C-terminus in the heart is unclear, because in AKAP 5 knockout mice calcineurin is no longer pulled down with the CaV1.2 macromolecular complex.90 AKAP 5 is also necessary for calcineurin association with caveolin-3 in the heart.90 This has important implications for the hypothesis that caveolae-localized, rather than dyadic LTCCs selectively activate calcineurin–NFAT signalling93 (Figure 3). It is unclear whether dyadic LTCCs are associated with calcineurin. From a design perspective, there may be an advantage to not having calcineurin associated with dyadic LTCCs, since modelling suggests that calcineurin at the dyadic cleft would be constitutively active due to the large local [Ca2+] generated by LTCCs and RyRs, and the high affinity of calcineurin for Ca2+-CaM.101 Overall, fundamental questions remain regarding how caveolae-localized LTCCs activate calcineurin/NFAT signalling in the heart.
Figure 3.

Schematic illustrating proposed dichotomous LTCC targeting and signalling in the heart. Dyadic CaV1.2 channels trigger calcium-induced calcium release that leads to contraction, whereas caveolae-localized CaV1.2 channels initiate NFAT signalling by activating the Ca2+-CaM-dependent protein phosphatase, calcineurin.
CaMKII is a multi-functional serine/threonine protein kinase with numerous biological functions in many cell types including the heart.110 The CaMKII holo-enzyme is a multimer of 12 monomeric subunits, each of which has three distinct domains: an N-terminal catalytic domain that mediates kinase activity, a central regulatory domain that exerts basal autoinhibitory control of the kinase domain, and an association domain that mediates subunit assembly.110,111 Ca2+-CaM activates CaMKII by binding the regulatory domain and relieving autoinhibition. Sustained elevations in Ca2+-CaM result in autophosphorylation of CaMKII that leads constitutive, Ca2+-CaM-independent enzymatic activity.111,112 There is overwhelming evidence that autonomous CaMKII activity is elevated and plays a prominent role in cardiac pathogenesis in animal models of HF,113,114 and in failing human heart.115,116 CaV1.2 channels in the heart display an activity-dependent facilitation of current amplitude that is mediated through activated CaMKII,117,118 and is an important mechanism for dynamically regulating cardiac contractility. However, when excessive, CaMKII-mediated enhancement of ICa,L contributes to a prolonged APD, increased incidence of early and delayed after-depolarizations (EADs and DADs), and a propensity for cardiac arrhythmias.119 CaMKII associates with and phosphorylates both the pore-forming α1C120 and the auxiliary β2 subunit.121 Evidence has been provided supporting the importance of phosporylation of both α1C118 and β2119,121 in CaMKII-mediated facilitation of ICa,L. It is unknown whether caveolae- and T-tubule-localized LTCCs differentially associate with CaMKII.
4. Dysregulation of L-type channel targeting and signalling in cardiac disease
Mutations of LTCC proteins are associated with multiple diseases of both electrical (arrhythmia) and mechanical (HF) phenotype. Gain-of-function mutations in Cav1.2, which cause near-complete loss of voltage-dependent channel inactivation and calcium overload in multiple tissues, are linked to Timothy syndrome122,123 which is notable for a long QT interval, ventricular arrhythmia, and also structural heart defects. Interestingly, the disease-causing mutations, G406R and G402S, were found within exons 8 and 8a, which are alternatively spliced in a mutually exclusive fashion. In patients with hypertrophic HF, aberrant splicing of the mutually exclusive exons 31 and 32 was detected such that re-expression of the foetal exon contributed to disease progression.124
Loss-of-function mutations in Cav1.2 occur in patients with Brugada syndrome which is characterized by a short QT interval and sudden cardiac death.125 When missense mutations at G490R and A39V were co-expressed with other LTCC subunits in CHO cells, a clear reduction of ICa,L was observed. Confocal microscopy studies revealed that channel trafficking was unaffected. Thus, it was hypothesized that the G490R mutation, which is located in a linker region, interferes with β subunit binding to inhibit current density. Another study revealed that a V2041I mutation in the C-terminus also reduces ICa,L amplitude by decreasing channel conductance and altering current inactivation.125
Abnormal EC coupling, resulting from deregulation at the onset of Ca2+ influx through the T-tubule network, is increasingly implicated in HF progression and sudden cardiac death.126,127 Measurements of whole-cell LTCC current density in cardiomyocytes from failing human hearts or animal models of HF either find a decrease128–131 or no change in ICa,L.132–134 Interestingly, in a canine tachycardia-induced model of HF CaV1.2 maximal gating charge (Qmax) was decreased by ∼60% even though whole-cell ICa,L was unchanged.134 Because Qmax provides a measure of the number of channels with moveable voltage sensors in the sarcolemma, this result implied that there were less surface CaV1.2 channels in this model of HF, but that the channels present were more active. Indeed, single-channel experiments found a higher open probability for LTCCs from failing compared with non-failing human ventricles.135 The heart content of Cav1.2, typically analysed by biochemical assay of heart muscle lysates, is not altered in failing hearts.52 However, while we recently confirmed that the total cellular Cav1.2 content is unchanged in HF, we also found that the channels are internalized.52 Testing the forward trafficking machinery of Cav1.2 in failing hearts, we found that human HF involves a reduction in BIN1 at both the protein and mRNA message level, implying that the reduction is transcriptional. Subsequent studies in adult cardiomyocytes confirmed that decreased BIN1 reduces forward trafficking of Cav1.2, also diminishing intracellular calcium transients (in isolated cells and zebrafish hearts) and contractility (of zebrafish hearts). Recent rat studies confirmed that BIN1 is decreased in failing hearts and recovers with successful treatment.136 It is therefore possible that reduced contractility of progressively failing heart can be traced, in part, to decreased transcription of the LTCC scaffold BIN1.
5. Perspectives
Cardiac Cav1.2 channels exist in multiple discrete sub-domains with the plasma membrane, including in different locations within each cardiac T-tubule and in caveolae. The channel itself, like all cardiac ion channels, is short lived with a half-life that is likely on the order of hours. Therefore, the channel's trafficking to specific sub-domains must be highly regulated and dynamic. The channel is heavily dependent on channel subunits, cardiac cytoskeleton, and scaffolding proteins for proper membrane localization. Existing data indicate that CaVβ subunits increase forward trafficking and prevent degradation, and extracellular subunits α2δ increase LTCC current. The γ subunit affects current density but is less well studied. Cav1.2 delivery to T-tubules is microtubule dependent and facilitated by the BIN1-scaffolding protein that occurs at T-tubule membrane. Data exist on other cardiac ion channels for the role of actin as rest stops on the way to the plasma membrane, and cytoskeleton-based specificity of delivery is an active area of investigation. The regulatory protein calmodulin affects both gating and channel trafficking, and distinctive properties of Ca2+-calmodulin association with calcineurin vs. CaM Kinase II may provide local signalling specificity to Cav1.2 channels. In failing cardiomyocytes, trafficking of channels to the plasma membranes is impaired, and the channels themselves undergo gating changes that increase open probability possibly as a compensatory result. In the future, detailed biochemical and imaging studies in cardiomyocytes and interpreted in the context of the LTCC life cycle (forward trafficking, existence on the membrane, and internalization) will help identify key regulators of this important channel.
Conflict of interest: none declared.
Funding
This work was supported by grants from the National Institutes of Health to H.M.C. (RO1HL069911) and R.M.S. (RO1HL094414). H.M.C. is an established Investigator of the American Heart Association.
References
- 1.Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol. 2000;16:521–555. doi: 10.1146/annurev.cellbio.16.1.521. doi:10.1146/annurev.cellbio.16.1.521. [DOI] [PubMed] [Google Scholar]
- 2.Tang ZZ, Liang MC, Lu S, Yu D, Yu CY, Yue DT, et al. Transcript scanning reveals novel and extensive splice variations in human l-type voltage-gated calcium channel, Cav1.2 alpha1 subunit. J Biol Chem. 2004;279:44335–44343. doi: 10.1074/jbc.M407023200. doi:10.1074/jbc.M407023200. [DOI] [PubMed] [Google Scholar]
- 3.Tang ZZ, Hong X, Wang J, Soong TW. Signature combinatorial splicing profiles of rat cardiac- and smooth-muscle Cav1.2 channels with distinct biophysical properties. Cell Calcium. 2007;41:417–428. doi: 10.1016/j.ceca.2006.08.002. doi:10.1016/j.ceca.2006.08.002. [DOI] [PubMed] [Google Scholar]
- 4.De Jongh KS, Murphy BJ, Colvin AA, Hell JW, Takahashi M, Catterall WA. Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3′,5′-cyclic monophosphate-dependent protein kinase. Biochemistry. 1996;35:10392–10402. doi: 10.1021/bi953023c. doi:10.1021/bi953023c. [DOI] [PubMed] [Google Scholar]
- 5.Hulme JT, Yarov-Yarovoy V, Lin TW, Scheuer T, Catterall WA. Autoinhibitory control of the CaV1.2 channel by its proteolytically processed distal C-terminal domain. J Physiol. 2006;576:87–102. doi: 10.1113/jphysiol.2006.111799. doi:10.1113/jphysiol.2006.111799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Fang K, Colecraft HM. Mechanism of auxiliary beta-subunit-mediated membrane targeting of L-type (Ca(V)1.2) channels. J Physiol. 2011;589:4437–4455. doi: 10.1113/jphysiol.2011.214247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Dai S, Hall DD, Hell JW. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev. 2009;89:411–452. doi: 10.1152/physrev.00029.2007. doi:10.1152/physrev.00029.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Fu Y, Westenbroek RE, Yu FH, Clark JP, 3rd, Marshall MR, Scheuer T, et al. Deletion of the distal C-terminus of Cav1.2 channel leads to loss of Beta-adrenergic regulation and heart failure in vivo. J Biol Chem. 2011;286:12617–12626. doi: 10.1074/jbc.M110.175307. doi:10.1152/physrev.00029.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dolphin AC. Beta subunits of voltage-gated calcium channels. J Bioenerg Biomembr. 2003;35:599–620. doi: 10.1023/b:jobb.0000008026.37790.5a. doi:10.1023/B:JOBB.0000008026.37790.5a. [DOI] [PubMed] [Google Scholar]
- 10.Buraei Z, Yang J. The {beta} subunit of voltage-gated Ca2+ channels. Physiol Rev. 2010;90:1461–1506. doi: 10.1152/physrev.00057.2009. doi:10.1152/physrev.00057.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Chen YH, Li MH, Zhang Y, He LL, Yamada Y, Fitzmaurice A, et al. Structural basis of the alpha1-beta subunit interaction of voltage-gated Ca2+ channels. Nature. 2004;429:675–680. doi: 10.1038/nature02641. doi:10.1038/nature02641. [DOI] [PubMed] [Google Scholar]
- 12.Opatowsky Y, Chen CC, Campbell KP, Hirsch JA. Structural analysis of the voltage-dependent calcium channel beta subunit functional core and its complex with the alpha 1 interaction domain. Neuron. 2004;42:387–399. doi: 10.1016/s0896-6273(04)00250-8. doi:10.1016/S0896-6273(04)00250-8. [DOI] [PubMed] [Google Scholar]
- 13.Van Petegem F, Clark KA, Chatelain FC, Minor DL., Jr Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain. Nature. 2004;429:671–675. doi: 10.1038/nature02588. doi:10.1038/nature02588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Pragnell M, De Waard M, Mori Y, Tanabe T, Snutch TP, Campbell KP. Calcium channel beta-subunit binds to a conserved motif in the I–II cytoplasmic linker of the alpha 1-subunit. Nature. 1994;368:67–70. doi: 10.1038/368067a0. doi:10.1038/368067a0. [DOI] [PubMed] [Google Scholar]
- 15.Waithe D, Ferron L, Page KM, Chaggar K, Dolphin AC. Beta-subunits promote the expression of Ca(V)2.2 channels by reducing their proteasomal degradation. J Biol Chem. 2011;286:9598–9611. doi: 10.1074/jbc.M110.195909. doi:10.1074/jbc.M110.195909. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Altier C, Garcia-Caballero A, Simms B, You H, Chen L, Walcher J, et al. The Cavbeta subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels. Nat Neurosci. 2011;14:173–180. doi: 10.1038/nn.2712. doi:10.1038/nn.2712. [DOI] [PubMed] [Google Scholar]
- 17.Meissner M, Weissgerber P, Londono JE, Prenen J, Link S, Ruppenthal S, et al. Moderate calcium channel dysfunction in adult mice with inducible cardiomyocyte-specific excision of the cacnb2 gene. J Biol Chem. 2011;286:15875–15882. doi: 10.1074/jbc.M111.227819. doi:10.1074/jbc.M111.227819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Takahashi SX, Mittman S, Colecraft HM. Distinctive modulatory effects of five human auxiliary beta 2 subunit splice variants on L-type calcium channel gating. Biophys J. 2003;84:3007–3021. doi: 10.1016/S0006-3495(03)70027-7. doi:10.1016/S0006-3495(03)70027-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hullin R, Khan IF, Wirtz S, Mohacsi P, Varadi G, Schwartz A, et al. Cardiac L-type calcium channel beta-subunits expressed in human heart have differential effects on single channel characteristics. J Biol Chem. 2003;278:21623–21630. doi: 10.1074/jbc.M211164200. doi:10.1074/jbc.M211164200. [DOI] [PubMed] [Google Scholar]
- 20.Foell JD, Balijepalli RC, Delisle BP, Yunker AM, Robia SL, Walker JW, et al. Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization. Physiol Genomics. 2004;17:183–200. doi: 10.1152/physiolgenomics.00207.2003. doi:10.1152/physiolgenomics.00207.2003. [DOI] [PubMed] [Google Scholar]
- 21.Weissgerber P, Held B, Bloch W, Kaestner L, Chien KR, Fleischmann BK, et al. Reduced cardiac L-type Ca2+ current in Ca(V)beta2−/− embryos impairs cardiac development and contraction with secondary defects in vascular maturation. Circ Res. 2006;99:749–757. doi: 10.1161/01.RES.0000243978.15182.c1. doi:10.1161/01.RES.0000243978.15182.c1. [DOI] [PubMed] [Google Scholar]
- 22.Cingolani E, Ramirez Correa GA, Kizana E, Murata M, Cho HC, Marban E. Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy. Circ Res. 2007;101:166–175. doi: 10.1161/CIRCRESAHA.107.155721. doi:10.1161/CIRCRESAHA.107.155721. [DOI] [PubMed] [Google Scholar]
- 23.Colecraft HM, Alseikhan B, Takahashi SX, Chaudhuri D, Mittman S, Yegnasubramanian V, et al. Novel functional properties of Ca(2+) channel beta subunits revealed by their expression in adult rat heart cells. J Physiol. 2002;541:435–452. doi: 10.1113/jphysiol.2002.018515. doi:10.1113/jphysiol.2002.018515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Chen X, Nakayama H, Zhang X, Ai X, Harris DM, Tang M, et al. Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy. J Mol Cell Cardiol. 2011;50:460–470. doi: 10.1016/j.yjmcc.2010.11.012. doi:10.1016/j.yjmcc.2010.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Dolphin AC. Calcium channel auxiliary alpha2delta and beta subunits: trafficking and one step beyond. Nat Rev Neurosci. 2012;13:542–555. doi: 10.1038/nrn3311. [DOI] [PubMed] [Google Scholar]
- 26.Bauer CS, Tran-Van-Minh A, Kadurin I, Dolphin AC. A new look at calcium channel alpha2delta subunits. Curr Opin Neurobiol. 2010;20:563–571. doi: 10.1016/j.conb.2010.05.007. doi:10.1016/j.conb.2010.05.007. [DOI] [PubMed] [Google Scholar]
- 27.Whittaker CA, Hynes RO. Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol Biol Cell. 2002;13:3369–3387. doi: 10.1091/mbc.E02-05-0259. doi:10.1091/mbc.E02-05-0259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Anantharaman V, Aravind L. Cache—a signaling domain common to animal Ca(2+)-channel subunits and a class of prokaryotic chemotaxis receptors. Trends Biochem Sci. 2000;25:535–537. doi: 10.1016/s0968-0004(00)01672-8. doi:10.1016/S0968-0004(00)01672-8. [DOI] [PubMed] [Google Scholar]
- 29.Gao B, Sekido Y, Maximov A, Saad M, Forgacs E, Latif F, et al. Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2) J Biol Chem. 2000;275:12237–12242. doi: 10.1074/jbc.275.16.12237. doi:10.1074/jbc.275.16.12237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Bangalore R, Mehrke G, Gingrich K, Hofmann F, Kass RS. Influence of L-type Ca channel alpha 2/delta-subunit on ionic and gating current in transiently transfected HEK 293 cells. Am J Physiol. 1996;270:H1521–H1528. doi: 10.1152/ajpheart.1996.270.5.H1521. [DOI] [PubMed] [Google Scholar]
- 31.Fuller-Bicer GA, Varadi G, Koch SE, Ishii M, Bodi I, Kadeer N, et al. Targeted disruption of the voltage-dependent calcium channel alpha2/delta-1-subunit. Am J Physiol Heart Circ Physiol. 2009;297:H117–H124. doi: 10.1152/ajpheart.00122.2009. doi:10.1152/ajpheart.00122.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Eroglu C, Allen NJ, Susman MW, O'Rourke NA, Park CY, Ozkan E, et al. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell. 2009;139:380–392. doi: 10.1016/j.cell.2009.09.025. doi:10.1016/j.cell.2009.09.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Chu PJ, Robertson HM, Best PM. Calcium channel gamma subunits provide insights into the evolution of this gene family. Gene. 2001;280:37–48. doi: 10.1016/s0378-1119(01)00738-7. doi:10.1016/S0378-1119(01)00738-7. [DOI] [PubMed] [Google Scholar]
- 34.Yang L, Katchman A, Morrow JP, Doshi D, Marx SO. Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits. FASEB J. 2011;25:928–936. doi: 10.1096/fj.10-172353. doi:10.1096/fj.10-172353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Halling DB, Aracena-Parks P, Hamilton SL. Regulation of voltage-gated Ca2+ channels by calmodulin. Sci STKE. 2005;2005:re15. doi: 10.1126/stke.3152005re15. doi:10.1126/stke.3152005re15. [DOI] [PubMed] [Google Scholar]
- 36.Peterson BZ, DeMaria CD, Adelman JP, Yue DT. Calmodulin is the Ca2+ sensor for Ca2+-dependent inactivation of L-type calcium channels. Neuron. 1999;22:549–558. doi: 10.1016/s0896-6273(00)80709-6. doi:10.1016/S0896-6273(00)80709-6. [DOI] [PubMed] [Google Scholar]
- 37.Zuhlke RD, Pitt GS, Deisseroth K, Tsien RW, Reuter H. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature. 1999;399:159–162. doi: 10.1038/20200. doi:10.1038/20200. [DOI] [PubMed] [Google Scholar]
- 38.Erickson MG, Alseikhan BA, Peterson BZ, Yue DT. Preassociation of calmodulin with voltage-gated Ca(2+) channels revealed by FRET in single living cells. Neuron. 2001;31:973–985. doi: 10.1016/s0896-6273(01)00438-x. doi:10.1016/S0896-6273(01)00438-X. [DOI] [PubMed] [Google Scholar]
- 39.Fallon JL, Halling DB, Hamilton SL, Quiocho FA. Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. Structure. 2005;13:1881–1886. doi: 10.1016/j.str.2005.09.021. doi:10.1016/j.str.2005.09.021. [DOI] [PubMed] [Google Scholar]
- 40.Van Petegem F, Chatelain FC, Minor DL., Jr Insights into voltage-gated calcium channel regulation from the structure of the CaV1.2 IQ domain-Ca2+/calmodulin complex. Nat Struct Mol Biol. 2005;12:1108–1115. doi: 10.1038/nsmb1027. doi:10.1038/nsmb1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Fallon JL, Baker MR, Xiong L, Loy RE, Yang G, Dirksen RT, et al. Crystal structure of dimeric cardiac L-type calcium channel regulatory domains bridged by Ca2+* calmodulins. Proc Natl Acad Sci USA. 2009;106:5135–5140. doi: 10.1073/pnas.0807487106. doi:10.1073/pnas.0807487106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kim EY, Rumpf CH, Van Petegem F, Arant RJ, Findeisen F, Cooley ES, et al. Multiple C-terminal tail Ca(2+)/CaMs regulate Ca(V)1.2 function but do not mediate channel dimerization. EMBO J. 2010;29:3924–3938. doi: 10.1038/emboj.2010.260. doi:10.1038/emboj.2010.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Wang HG, George MS, Kim J, Wang C, Pitt GS. Ca2+/calmodulin regulates trafficking of Ca(V)1.2 Ca2+ channels in cultured hippocampal neurons. J Neurosci. 2007;27:9086–9093. doi: 10.1523/JNEUROSCI.1720-07.2007. doi:10.1523/JNEUROSCI.1720-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Alseikhan BA, DeMaria CD, Colecraft HM, Yue DT. Engineered calmodulins reveal the unexpected eminence of Ca2+ channel inactivation in controlling heart excitation. Proc Natl Acad Sci USA. 2002;99:17185–17190. doi: 10.1073/pnas.262372999. doi:10.1073/pnas.262372999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Blaich A, Pahlavan S, Tian Q, Oberhofer M, Poomvanicha M, Lenhardt P, et al. Mutation of the calmodulin binding motif IQ of the L-type Ca(v)1.2 Ca2+ channel to EQ induces dilated cardiomyopathy and death. J Biol Chem. 2012;287:22616–22625. doi: 10.1074/jbc.M112.357921. doi:10.1074/jbc.M112.357921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Soonpaa MH, Rubart M, Field LJ. Challenges measuring cardiomyocyte renewal. Biochim Biophys Acta. 2012 doi: 10.1016/j.bbamcr.2012.10.029. (In press) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Beardslee MA, Laing JG, Beyer EC, Saffitz JE. Rapid turnover of connexin43 in the adult rat heart. Circ Res. 1998;83:629–635. doi: 10.1161/01.res.83.6.629. doi:10.1161/01.RES.83.6.629. [DOI] [PubMed] [Google Scholar]
- 48.Colley BS, Biju KC, Visegrady A, Campbell S, Fadool DA. Neurotrophin B receptor kinase increases Kv subfamily member 1.3 (Kv1.3) ion channel half-life and surface expression. Neuroscience. 2007;144:531–546. doi: 10.1016/j.neuroscience.2006.09.055. doi:10.1016/j.neuroscience.2006.09.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Chien AJ, Zhao X, Shirokov RE, Puri TS, Chang CF, Sun D, et al. Roles of a membrane-localized beta subunit in the formation and targeting of functional L-type Ca2+ channels. J Biol Chem. 1995;270:30036–30044. doi: 10.1074/jbc.270.50.30036. doi:10.1074/jbc.270.50.30036. [DOI] [PubMed] [Google Scholar]
- 50.Hong TT, Smyth JW, Gao D, Chu KY, Vogan JM, Fong TS, et al. BIN1 localizes the L-type calcium channel to cardiac T-tubules. PLoS Biol. 2010;8:e1000312. doi: 10.1371/journal.pbio.1000312. doi:10.1371/journal.pbio.1000312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Smyth JW, Hong TT, Gao D, Vogan JM, Jensen BC, Fong TS, et al. Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium. J Clin Invest. 2010;120:266–279. doi: 10.1172/JCI39740. doi:10.1172/JCI39740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Hong TT, Smyth JW, Chu KY, Vogan JM, Fong TS, Jensen BC, et al. BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes. Heart Rhythm. 2012;9:812–820. doi: 10.1016/j.hrthm.2011.11.055. doi:10.1016/j.hrthm.2011.11.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Smyth JW, Vogan JM, Buch PJ, Zhang SS, Fong TS, Hong TT, et al. Actin cytoskeleton rest stops regulate anterograde traffic of connexin 43 vesicles to the plasma membrane. Circ Res. 2012;110:978–989. doi: 10.1161/CIRCRESAHA.111.257964. doi:10.1161/CIRCRESAHA.111.257964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Taba T, Edamatsu M, Toba S, Shibata K, Imafuku Y, Toyoshima YY, et al. Direction and speed of microtubule movements driven by kinesin motors arranged on catchin thick filaments. Cell Motil Cytoskeleton. 2008;65:816–826. doi: 10.1002/cm.20303. doi:10.1002/cm.20303. [DOI] [PubMed] [Google Scholar]
- 55.Hirokawa N, Noda Y, Okada Y. Kinesin and dynein superfamily proteins in organelle transport and cell division. Curr Opin Cell Biol. 1998;10:60–73. doi: 10.1016/s0955-0674(98)80087-2. doi:10.1016/S0955-0674(98)80087-2. [DOI] [PubMed] [Google Scholar]
- 56.Gardner MK, Zanic M, Howard J. Microtubule catastrophe and rescue. Curr Opin Cell Biol. 2012;25:14–22. doi: 10.1016/j.ceb.2012.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Catalucci D, Zhang DH, DeSantiago J, Aimond F, Barbara G, Chemin J, et al. Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. J Cell Biol. 2009;184:923–933. doi: 10.1083/jcb.200805063. doi:10.1083/jcb.200805063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Hamm-Alvarez SF, Sheetz MP. Microtubule-dependent vesicle transport: modulation of channel and transporter activity in liver and kidney. Physiol Rev. 1998;78:1109–1129. doi: 10.1152/physrev.1998.78.4.1109. [DOI] [PubMed] [Google Scholar]
- 59.Gaietta G, Deerinck TJ, Adams SR, Bouwer J, Tour O, Laird DW, et al. Multicolor and electron microscopic imaging of connexin trafficking. Science. 2002;296:503–507. doi: 10.1126/science.1068793. doi:10.1126/science.1068793. [DOI] [PubMed] [Google Scholar]
- 60.Shaw RM, Fay AJ, Puthenveedu MA, von Zastrow M, Jan YN, Jan LY. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell. 2007;128:547–560. doi: 10.1016/j.cell.2006.12.037. doi:10.1016/j.cell.2006.12.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Johnson RG, Meyer RA, Li XR, Preus DM, Tan L, Grunenwald H, et al. Gap junctions assemble in the presence of cytoskeletal inhibitors, but enhanced assembly requires microtubules. Exp Cell Res. 2002;275:67–80. doi: 10.1006/excr.2002.5480. doi:10.1006/excr.2002.5480. [DOI] [PubMed] [Google Scholar]
- 62.Lauf U, Giepmans BN, Lopez P, Braconnot S, Chen SC, Falk MM. Dynamic trafficking and delivery of connexons to the plasma membrane and accretion to gap junctions in living cells. Proc Natl Acad Sci USA. 2002;99:10446–10451. doi: 10.1073/pnas.162055899. doi:10.1073/pnas.162055899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Zadeh AD, Cheng Y, Xu H, Wong N, Wang Z, Goonasekara C, et al. Kif5b is an essential forward trafficking motor for the Kv1.5 cardiac potassium channel. J Physiol. 2009;587:4565–4574. doi: 10.1113/jphysiol.2009.178442. doi:10.1113/jphysiol.2009.178442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Smyth JW, Shaw RM. Forward trafficking of ion channels: what the clinician needs to know. Heart Rhythm. 2010;7:1135–1140. doi: 10.1016/j.hrthm.2010.05.030. doi:10.1016/j.hrthm.2010.05.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Yasuda T, Chen L, Barr W, McRory JE, Lewis RJ, Adams DJ, et al. Auxiliary subunit regulation of high-voltage activated calcium channels expressed in mammalian cells. Eur J Neurosci. 2004;20:1–13. doi: 10.1111/j.1460-9568.2004.03434.x. doi:10.1111/j.1460-9568.2004.03434.x. [DOI] [PubMed] [Google Scholar]
- 66.Simms BA, Zamponi GW. Trafficking and stability of voltage-gated calcium channels. Cell Mol Life Sci. 2012;69:843–856. doi: 10.1007/s00018-011-0843-y. doi:10.1007/s00018-011-0843-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Tang BL. Protein trafficking mechanisms associated with neurite outgrowth and polarized sorting in neurons. J Neurochem. 2001;79:923–930. doi: 10.1046/j.1471-4159.2001.00674.x. doi:10.1046/j.1471-4159.2001.00674.x. [DOI] [PubMed] [Google Scholar]
- 68.Soeller C, Cannell MB. Examination of the transverse tubular system in living cardiac rat myocytes by 2-photon microscopy and digital image-processing techniques. Circ Res. 1999;84:266–275. doi: 10.1161/01.res.84.3.266. doi:10.1161/01.RES.84.3.266. [DOI] [PubMed] [Google Scholar]
- 69.Savio-Galimberti E, Frank J, Inoue M, Goldhaber JI, Cannell MB, Bridge JH, et al. Novel features of the rabbit transverse tubular system revealed by quantitative analysis of three-dimensional reconstructions from confocal images. Biophys J. 2008;95:2053–2062. doi: 10.1529/biophysj.108.130617. doi:10.1529/biophysj.108.130617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Brette F, Orchard C. T-tubule function in mammalian cardiac myocytes. Circ Res. 2003;92:1182–1192. doi: 10.1161/01.RES.0000074908.17214.FD. doi:10.1161/01.RES.0000074908.17214.FD. [DOI] [PubMed] [Google Scholar]
- 71.Seki S, Nagashima M, Yamada Y, Tsutsuura M, Kobayashi T, Namiki A, et al. Fetal and postnatal development of Ca2+ transients and Ca2+ sparks in rat cardiomyocytes. Cardiovasc Res. 2003;58:535–548. doi: 10.1016/s0008-6363(03)00255-4. doi:10.1016/S0008-6363(03)00255-4. [DOI] [PubMed] [Google Scholar]
- 72.Bossen EH, Sommer JR. Comparative stereology of the lizard and frog myocardium. Tissue Cell. 1984;16:173–178. doi: 10.1016/0040-8166(84)90042-9. doi:10.1016/0040-8166(84)90042-9. [DOI] [PubMed] [Google Scholar]
- 73.Bossen EH, Sommer JR, Waugh RA. Comparative stereology of the mouse and finch left ventricle. Tissue Cell. 1978;10:773–784. doi: 10.1016/0040-8166(78)90062-9. doi:10.1016/0040-8166(78)90062-9. [DOI] [PubMed] [Google Scholar]
- 74.Leach RN, Desai JC, Orchard CH. Effect of cytoskeleton disruptors on L-type Ca channel distribution in rat ventricular myocytes. Cell Calcium. 2005;38:515–526. doi: 10.1016/j.ceca.2005.07.006. doi:10.1016/j.ceca.2005.07.006. [DOI] [PubMed] [Google Scholar]
- 75.Tian Q, Pahlavan S, Oleinikow K, Jung J, Ruppenthal S, Scholz A, et al. Functional and morphological preservation of adult ventricular myocytes in culture by sub-micromolar cytochalasin D supplement. J Mol Cell Cardiol. 2012;52:113–124. doi: 10.1016/j.yjmcc.2011.09.001. doi:10.1016/j.yjmcc.2011.09.001. [DOI] [PubMed] [Google Scholar]
- 76.Lyon AR, MacLeod KT, Zhang Y, Garcia E, Kanda GK, Lab MJ, et al. Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart. Proc Natl Acad Sci USA. 2009;106:6854–6859. doi: 10.1073/pnas.0809777106. doi:10.1073/pnas.0809777106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Wagner E, Lauterbach MA, Kohl T, Westphal V, Williams GS, Steinbrecher JH, et al. Stimulated emission depletion live-cell super-resolution imaging shows proliferative remodeling of T-tubule membrane structures after myocardial infarction. Circ Res. 2012;111:402–414. doi: 10.1161/CIRCRESAHA.112.274530. doi:10.1161/CIRCRESAHA.112.274530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Heinzel FR, Bito V, Biesmans L, Wu M, Detre E, von Wegner F, et al. Remodeling of T-tubules and reduced synchrony of Ca2+ release in myocytes from chronically ischemic myocardium. Circ Res. 2008;102:338–346. doi: 10.1161/CIRCRESAHA.107.160085. doi:10.1161/CIRCRESAHA.107.160085. [DOI] [PubMed] [Google Scholar]
- 79.He J, Conklin MW, Foell JD, Wolff MR, Haworth RA, Coronado R, et al. Reduction in density of transverse tubules and L-type Ca(2+) channels in canine tachycardia-induced heart failure. Cardiovasc Res. 2001;49:298–307. doi: 10.1016/s0008-6363(00)00256-x. doi:10.1016/S0008-6363(00)00256-X. [DOI] [PubMed] [Google Scholar]
- 80.Balijepalli RC, Kamp TJ. Cardiomyocyte transverse tubule loss leads the way to heart failure. Future Cardiol. 2011;7:39–42. doi: 10.2217/fca.10.113. doi:10.2217/fca.10.113. [DOI] [PubMed] [Google Scholar]
- 81.Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010;107:1047–1057. doi: 10.1161/CIRCRESAHA.110.226456. doi:10.1161/CIRCRESAHA.110.226456. [DOI] [PubMed] [Google Scholar]
- 82.Hong TT, Cogswell R, James CA, Kang G, Pullinger CR, Malloy MJ, et al. Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2012;9:961–967. doi: 10.1016/j.hrthm.2012.01.024. doi:10.1016/j.hrthm.2012.01.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Gonzalez-Gutierrez G, Miranda-Laferte E, Neely A, Hidalgo P. The Src homology 3 domain of the beta-subunit of voltage-gated calcium channels promotes endocytosis via dynamin interaction. J Biol Chem. 2007;282:2156–2162. doi: 10.1074/jbc.M609071200. doi:10.1074/jbc.M609071200. [DOI] [PubMed] [Google Scholar]
- 84.Green EM, Barrett CF, Bultynck G, Shamah SM, Dolmetsch RE. The tumor suppressor eIF3e mediates calcium-dependent internalization of the L-type calcium channel CaV1.2. Neuron. 2007;55:615–632. doi: 10.1016/j.neuron.2007.07.024. doi:10.1016/j.neuron.2007.07.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Dolphin AC. Calcium channel diversity: multiple roles of calcium channel subunits. Curr Opin Neurobiol. 2009;19:237–244. doi: 10.1016/j.conb.2009.06.006. doi:10.1016/j.conb.2009.06.006. [DOI] [PubMed] [Google Scholar]
- 86.Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev. 2004;84:1341–1379. doi: 10.1152/physrev.00046.2003. doi:10.1152/physrev.00046.2003. [DOI] [PubMed] [Google Scholar]
- 87.Briand N, Dugail I, Le Lay S. Cavin proteins: New players in the caveolae field. Biochimie. 2011;93:71–77. doi: 10.1016/j.biochi.2010.03.022. doi:10.1016/j.biochi.2010.03.022. [DOI] [PubMed] [Google Scholar]
- 88.Levin KR, Page E. Quantitative studies on plasmalemmal folds and caveolae of rabbit ventricular myocardial cells. Circ Res. 1980;46:244–255. doi: 10.1161/01.res.46.2.244. doi:10.1161/01.RES.46.2.244. [DOI] [PubMed] [Google Scholar]
- 89.Balijepalli RC, Foell JD, Hall DD, Hell JW, Kamp TJ. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci USA. 2006;103:7500–7505. doi: 10.1073/pnas.0503465103. doi:10.1073/pnas.0503465103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Nichols CB, Rossow CF, Navedo MF, Westenbroek RE, Catterall WA, Santana LF, et al. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res. 2010;107:747–756. doi: 10.1161/CIRCRESAHA.109.216127. doi:10.1161/CIRCRESAHA.109.216127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Scriven DR, Klimek A, Asghari P, Bellve K, Moore ED. Caveolin-3 is adjacent to a group of extradyadic ryanodine receptors. Biophys J. 2005;89:1893–1901. doi: 10.1529/biophysj.105.064212. doi:10.1529/biophysj.105.064212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Cavalli A, Eghbali M, Minosyan TY, Stefani E, Philipson KD. Localization of sarcolemmal proteins to lipid rafts in the myocardium. Cell Calcium. 2007;42:313–322. doi: 10.1016/j.ceca.2007.01.003. doi:10.1016/j.ceca.2007.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Makarewich CA, Correll RN, Gao H, Zhang H, Yang B, Berretta RM, et al. A caveolae-targeted L-type Ca(2)+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility. Circ Res. 2012;110:669–674. doi: 10.1161/CIRCRESAHA.111.264028. doi:10.1161/CIRCRESAHA.111.264028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Calaghan S, White E. Caveolae modulate excitation-contraction coupling and beta2-adrenergic signalling in adult rat ventricular myocytes. Cardiovasc Res. 2006;69:816–824. doi: 10.1016/j.cardiores.2005.10.006. doi:10.1016/j.cardiores.2005.10.006. [DOI] [PubMed] [Google Scholar]
- 95.George MS, Pitt GS. The real estate of cardiac signaling: location, location, location. Proc Natl Acad Sci USA. 2006;103:7535–7536. doi: 10.1073/pnas.0602389103. doi:10.1073/pnas.0602389103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Beguin P, Nagashima K, Gonoi T, Shibasaki T, Takahashi K, Kashima Y, et al. Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem. Nature. 2001;411:701–706. doi: 10.1038/35079621. doi:10.1038/35079621. [DOI] [PubMed] [Google Scholar]
- 97.Finlin BS, Crump SM, Satin J, Andres DA. Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases. Proc Natl Acad Sci USA. 2003;100:14469–14474. doi: 10.1073/pnas.2437756100. doi:10.1073/pnas.2437756100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Yang T, Suhail Y, Dalton S, Kernan T, Colecraft HM. Genetically encoded molecules for inducibly inactivating CaV channels. Nat Chem Biol. 2007;3:795–804. doi: 10.1038/nchembio.2007.42. doi:10.1038/nchembio.2007.42. [DOI] [PubMed] [Google Scholar]
- 99.Yang T, Xu X, Kernan T, Wu V, Colecraft HM. Rem, a member of the RGK GTPases, inhibits recombinant CaV1.2 channels using multiple mechanisms that require distinct conformations of the GTPase. J Physiol. 2010;588:1665–1681. doi: 10.1113/jphysiol.2010.187203. doi:10.1113/jphysiol.2010.187203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Feron O, Saldana F, Michel JB, Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem. 1998;273:3125–3128. doi: 10.1074/jbc.273.6.3125. doi:10.1074/jbc.273.6.3125. [DOI] [PubMed] [Google Scholar]
- 101.Saucerman JJ, Bers DM. Calmodulin binding proteins provide domains of local Ca2+ signaling in cardiac myocytes. J Mol Cell Cardiol. 2012;52:312–316. doi: 10.1016/j.yjmcc.2011.06.005. doi:10.1016/j.yjmcc.2011.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Mori MX, Erickson MG, Yue DT. Functional stoichiometry and local enrichment of calmodulin interacting with Ca2+ channels. Science. 2004;304:432–435. doi: 10.1126/science.1093490. doi:10.1126/science.1093490. [DOI] [PubMed] [Google Scholar]
- 103.Li H, Rao A, Hogan PG. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol. 2011;21:91–103. doi: 10.1016/j.tcb.2010.09.011. doi:10.1016/j.tcb.2010.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res. 2004;94:110–118. doi: 10.1161/01.RES.0000109415.17511.18. doi:10.1161/01.RES.0000109415.17511.18. [DOI] [PubMed] [Google Scholar]
- 105.Heineke J, Ritter O. Cardiomyocyte calcineurin signaling in subcellular domains: from the sarcolemma to the nucleus and beyond. J Mol Cell Cardiol. 2012;52:62–73. doi: 10.1016/j.yjmcc.2011.10.018. doi:10.1016/j.yjmcc.2011.10.018. [DOI] [PubMed] [Google Scholar]
- 106.Chiang CS, Huang CH, Chieng H, Chang YT, Chang D, Chen JJ, et al. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res. 2009;104:522–530. doi: 10.1161/CIRCRESAHA.108.184051. doi:10.1161/CIRCRESAHA.108.184051. [DOI] [PubMed] [Google Scholar]
- 107.Wu X, Eder P, Chang B, Molkentin JD. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci USA. 2010;107:7000–7005. doi: 10.1073/pnas.1001825107. doi:10.1073/pnas.1001825107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Gao H, Wang F, Wang W, Makarewich CA, Zhang H, Kubo H, et al. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling. J Mol Cell Cardiol. 2012;53:657–667. doi: 10.1016/j.yjmcc.2012.08.005. doi:10.1016/j.yjmcc.2012.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Tandan S, Wang Y, Wang TT, Jiang N, Hall DD, Hell JW, et al. Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel. Circ Res. 2009;105:51–60. doi: 10.1161/CIRCRESAHA.109.199828. doi:10.1161/CIRCRESAHA.109.199828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Erickson JR, He BJ, Grumbach IM, Anderson ME. CaMKII in the cardiovascular system: sensing redox states. Physiol Rev. 2011;91:889–915. doi: 10.1152/physrev.00018.2010. doi:10.1152/physrev.00018.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Chao LH, Stratton MM, Lee IH, Rosenberg OS, Levitz J, Mandell DJ, et al. A mechanism for tunable autoinhibition in the structure of a human Ca2+/calmodulin-dependent kinase II holoenzyme. Cell. 2011;146:732–745. doi: 10.1016/j.cell.2011.07.038. doi:10.1016/j.cell.2011.07.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.De Koninck P, Schulman H. Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science. 1998;279:227–230. doi: 10.1126/science.279.5348.227. doi:10.1126/science.279.5348.227. [DOI] [PubMed] [Google Scholar]
- 113.Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J, Jr, Bers DM, et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res. 2003;92:912–919. doi: 10.1161/01.RES.0000069686.31472.C5. doi:10.1161/01.RES.0000069686.31472.C5. [DOI] [PubMed] [Google Scholar]
- 114.Zhu WZ, Wang SQ, Chakir K, Yang D, Zhang T, Brown JH, et al. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest. 2003;111:617–625. doi: 10.1172/JCI16326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Hoch B, Meyer R, Hetzer R, Krause EG, Karczewski P. Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res. 1999;84:713–721. doi: 10.1161/01.res.84.6.713. doi:10.1161/01.RES.84.6.713. [DOI] [PubMed] [Google Scholar]
- 116.Kirchhefer U, Schmitz W, Scholz H, Neumann J. Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res. 1999;42:254–261. doi: 10.1016/s0008-6363(98)00296-x. doi:10.1016/S0008-6363(98)00296-X. [DOI] [PubMed] [Google Scholar]
- 117.Dzhura I, Wu Y, Colbran RJ, Balser JR, Anderson ME. Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol. 2000;2:173–177. doi: 10.1038/35004052. doi:10.1038/35004052. [DOI] [PubMed] [Google Scholar]
- 118.Blaich A, Welling A, Fischer S, Wegener JW, Kostner K, Hofmann F, et al. Facilitation of murine cardiac L-type Ca(v)1.2 channel is modulated by calmodulin kinase II-dependent phosphorylation of S1512 and S1570. Proc Natl Acad Sci USA. 2010;107:10285–10289. doi: 10.1073/pnas.0914287107. doi:10.1073/pnas.0914287107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Koval OM, Guan X, Wu Y, Joiner ML, Gao Z, Chen B, et al. CaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations. Proc Natl Acad Sci USA. 2010;107:4996–5000. doi: 10.1073/pnas.0913760107. doi:10.1073/pnas.0913760107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Hudmon A, Schulman H, Kim J, Maltez JM, Tsien RW, Pitt GS. CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation. J Cell Biol. 2005;171:537–547. doi: 10.1083/jcb.200505155. doi:10.1083/jcb.200505155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Grueter CE, Abiria SA, Dzhura I, Wu Y, Ham AJ, Mohler PJ, et al. L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII. Mol Cell. 2006;23:641–650. doi: 10.1016/j.molcel.2006.07.006. doi:10.1016/j.molcel.2006.07.006. [DOI] [PubMed] [Google Scholar]
- 122.Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119:19–31. doi: 10.1016/j.cell.2004.09.011. doi:10.1016/j.cell.2004.09.011. [DOI] [PubMed] [Google Scholar]
- 123.Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA. 2005;102:8089–8096. doi: 10.1073/pnas.0502506102. iscussion 8086–8088 doi:10.1073/pnas.0502506102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Yang Y, Chen X, Margulies K, Jeevanandam V, Pollack P, Bailey BA, et al. L-type Ca2+ channel alpha 1c subunit isoform switching in failing human ventricular myocardium. J Mol Cell Cardiol. 2000;32:973–984. doi: 10.1006/jmcc.2000.1138. doi:10.1006/jmcc.2000.1138. [DOI] [PubMed] [Google Scholar]
- 125.Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115:442–449. doi: 10.1161/CIRCULATIONAHA.106.668392. doi:10.1161/CIRCULATIONAHA.106.668392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Bito V, Heinzel FR, Weidemann F, Dommke C, van der Velden J, Verbeken E, et al. Cellular mechanisms of contractile dysfunction in hibernating myocardium. Circ Res. 2004;94:794–801. doi: 10.1161/01.RES.0000124934.84048.DF. doi:10.1161/01.RES.0000124934.84048.DF. [DOI] [PubMed] [Google Scholar]
- 127.Antoons G, Sipido KR. Targeting calcium handling in arrhythmias. Europace. 2008;10:1364–1369. doi: 10.1093/europace/eun271. doi:10.1093/europace/eun271. [DOI] [PubMed] [Google Scholar]
- 128.Mukherjee R, Hewett KW, Spinale FG. Myocyte electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy. J Mol Cell Cardiol. 1995;27:1333–1348. doi: 10.1016/s0022-2828(05)82396-x. doi:10.1016/S0022-2828(05)82396-X. [DOI] [PubMed] [Google Scholar]
- 129.Mukherjee R, Hewett KW, Walker JD, Basler CG, Spinale FG. Changes in L-type calcium channel abundance and function during the transition to pacing-induced congestive heart failure. Cardiovasc Res. 1998;37:432–444. doi: 10.1016/s0008-6363(97)00128-4. doi:10.1016/S0008-6363(97)00128-4. [DOI] [PubMed] [Google Scholar]
- 130.Mukherjee R, Spinale FG. L-type calcium channel abundance and function with cardiac hypertrophy and failure: a review. J Mol Cell Cardiol. 1998;30:1899–1916. doi: 10.1006/jmcc.1998.0755. doi:10.1006/jmcc.1998.0755. [DOI] [PubMed] [Google Scholar]
- 131.Briston SJ, Caldwell JL, Horn MA, Clarke JD, Richards MA, Greensmith DJ, et al. Impaired beta-adrenergic responsiveness accentuates dysfunctional excitation-contraction coupling in an ovine model of tachypacing-induced heart failure. J Physiol. 2011;589:1367–1382. doi: 10.1113/jphysiol.2010.203984. doi:10.1113/jphysiol.2010.203984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Beuckelmann DJ, Nabauer M, Erdmann E. Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol. 1991;23:929–937. doi: 10.1016/0022-2828(91)90135-9. doi:10.1016/0022-2828(91)90135-9. [DOI] [PubMed] [Google Scholar]
- 133.Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 1996;78:262–273. doi: 10.1161/01.res.78.2.262. doi:10.1161/01.RES.78.2.262. [DOI] [PubMed] [Google Scholar]
- 134.He J, Conklin MW, Foell JD, Wolff MR, Haworth RA, Coronado R, et al. Reduction in density of transverse tubules and L-type Ca(2+) channels in canine tachycardia-induced heart failure. Cardiovasc Res. 2001;49:298–307. doi: 10.1016/s0008-6363(00)00256-x. doi:10.1016/S0008-6363(00)00256-X. [DOI] [PubMed] [Google Scholar]
- 135.Schroder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, et al. Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation. 1998;98:969–976. doi: 10.1161/01.cir.98.10.969. doi:10.1161/01.CIR.98.10.969. [DOI] [PubMed] [Google Scholar]
- 136.Lyon AR, Nikolaev VO, Miragoli M, Sikkel MB, Paur H, Benard L, et al. Plasticity of surface structures and beta2-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure. Circ Heart Fail. 2012;5:357–365. doi: 10.1161/CIRCHEARTFAILURE.111.964692. [DOI] [PMC free article] [PubMed] [Google Scholar]

